Financial details of the transaction have yet to be disclosed by either company.
DePuy Synthes will acquire JointPoint’s surgeon-friendly navigation software, which helps surgeons generate more reproducible clinical outcomes.
Designed to enable better surgical outcomes, JointPoint Navigation Software offers precise analysis for implant selection and positioning in hip replacements procedures.
The software works by facilitating non-invasive computer navigation, case planning and digital templating before the surgery.
It also comes with OneTrial functionality, which requires only two images to optimise implant combinations according to pre-surgical goals. This feature is designed to limit retrial and reduce time in the operating room (OR).
DePuy Synthes Hips vice-president and global platform leader Aaron Villaruz said: “JointPoint ties into our strategy to transform hip replacement and is specifically designed for use with the Anterior Approach, a tissue-sparing surgical technique which surgeons are increasingly utilising and where we have long had an industry-leading presence.”
DePuy Synthes intends to expand the use of the JointPoint navigation software for other orthopaedic surgeries.
The company has been exclusively co-marketing the platform in the US since July 2017.
Following the closing of the acquisition, which is expected to occur by the end of the year, the software will become a component of DePuy Synthes’ Anterior Advantage solution.
The Anterior Approach solution combines implants, instrumentation and technologies designed to improve the patient’s surgical experience. It also comprises a professional education programme for reducing the learning curve and rising surgical reproducibility.
One of the components of Anterior Advantage is Kincise Surgical Automated System, designed to automate and improve the hip replacement surgery. It is said to be compatible with the JointPoint navigation software.
The solution also consists of the ACTIS Total Hip System component.